|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
gptkb:EMD_Serono
gptkb:Millipore
gptkb:Tetra_Logic_Pharmaceuticals
gptkb:Amesbury_Truth
gptkb:Viva_Biotech
gptkb:Sigma-Aldrich
gptkb:Millipore_Corporation
gptkb:Nant_Kwest
gptkb:Celerion
gptkb:Bio_Reliance
gptkb:Versum_Materials
Intermolecular
Astra Zeneca's cardiovascular assets
Astra Zeneca's diabetes assets
Astra Zeneca's drug portfolio
Astra Zeneca's infectious diseases assets
Astra Zeneca's inflammation assets
Astra Zeneca's metabolic diseases assets
Astra Zeneca's neuroscience assets
Astra Zeneca's oncology assets
Astra Zeneca's rare diseases assets
Astra Zeneca's respiratory assets
Astra Zeneca's rights to a drug
|
|
gptkbp:ceo
|
gptkb:Belen_Garijo
|
|
gptkbp:employees
|
~58,000 (2020)
|
|
gptkbp:focus_area
|
Healthcare
Life Science
Performance Materials
|
|
gptkbp:founded
|
1668
|
|
gptkbp:founder
|
gptkb:Friedrich_Jacob_Merck
|
|
gptkbp:headquarters
|
gptkb:Darmstadt,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Merck KGa A Pharmaceuticals
|
|
gptkbp:industry
|
Pharmaceuticals
|
|
gptkbp:operates_in
|
More than 70 countries
|
|
gptkbp:parent_company
|
gptkb:Merck_Group
|
|
gptkbp:partnership
|
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Roche
gptkb:Bayer
|
|
gptkbp:pharmaceutical_research
|
gptkb:Oncology
Immunology
Neurology
Endocrinology
|
|
gptkbp:products
|
Prescription drugs
Biopharmaceuticals
Over-the-counter drugs
|
|
gptkbp:revenue
|
€23.5 billion (2020)
|
|
gptkbp:stock_exchange
|
gptkb:Frankfurt_Stock_Exchange
|
|
gptkbp:stock_symbol
|
MRK
|
|
gptkbp:subsidiary
|
gptkb:Millipore_Sigma
|
|
gptkbp:website
|
www.merckgroup.com
|
|
gptkbp:bfsParent
|
gptkb:Merck_KGa_A
|
|
gptkbp:bfsLayer
|
4
|